Trial
NCT01148966
Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Washington
Collaborators
National Cancer Institute (NCI)
Condition
Adult Anaplastic Astrocytoma
Intervention
aminolevulinic acid
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-02-15